MedTrace Logo

Meperidine as the Single Sedative Agent During Esophagogastroduodenoscopy

NCT01547520 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2012-03-08

No results posted yet for this study

Summary

Upper endoscopy is uncomfortable for most patients. Meperidine has both sedative and analgesic effects, so its use may be helpful for patients receiving upper endoscopy.

Conditions

  • Esophagogastroduodenoscopy

Interventions

DRUG

Meperidine

intramuscular, 25 mg, 5 to 10 minutes before EGD

DRUG

normal saline

25 ml of normal saline, intramuscular, 5 to 10 minutes before EGD

Sponsors & Collaborators

  • Dalin Tzu Chi General Hospital

    lead OTHER

Principal Investigators

  • Yu-Hsi Hsieh, Dr. · Dalin Tzu Chi General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01547520 on ClinicalTrials.gov